SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
小宋爱科研
Lv4
1
510 积分
2021-02-22 加入
最近求助
最近应助
互助留言
Biomarkers for immunotherapy of hepatocellular carcinoma
18天前
已完结
Immune checkpoint inhibitors in HCC: Cellular, molecular and systemic data
18天前
已完结
Mechanisms of drug resistance in HCC
18天前
已完结
Contrast-enhanced CT parameters predict short-term tumor response in patients with hepatocellular carcinoma who received sequential combined anti-angiogenesis and immune checkpoint inhibitor treatment
25天前
已完结
Tumor-Infiltrating T Cells — A Portrait
1个月前
已完结
CXCL9+ Macrophage-targeted NIR-II aggregation-induced emission nanoprobes for the early diagnosis of myocarditis
1个月前
已完结
Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial
2个月前
已完结
Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial
2个月前
已完结
Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial
3个月前
已完结
PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [177Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, phase 2 trial
3个月前
已完结
没有进行任何应助
感谢
25天前
速度真快
1个月前
速度真快
2个月前
帮大忙了
2个月前
速度真快
3个月前
感谢
3个月前
不用啦【积分已退回】
4个月前
帮大忙了
6个月前
感谢,点赞,速度真快,帮大忙了,么么哒
7个月前
速度真快,点赞,帮大忙了,么么哒
7个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论